Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Motor Neuron Disease Association has published a blog post from Martin Turner about 'BioMOx', the Oxford Study for Biomarkers in MND.

Between 2009 and 2013, over 70 people living with MND (and some healthy people of similar age for comparison), took part in a new type of patient-based study. Men and women of all ages (from 28 to 86), some with primary lateral sclerosis (PLS) as well as a range of the more common amyotrophic lateral sclerosis (ALS) types, all gave up their time to attend for a day or two of tests in Oxford.

Read full text...

More about Martin Turner

More about BioMOx

Similar stories

Heidi Johansen-Berg elected a Fellow of the Royal Society

Professor Heidi Johansen-Berg, Professor of Cognitive Neuroscience has been honoured by the Royal Society by being elected a Fellow for her outstanding contributions to science.